Back
CytoDyn 10K Form
Sell
29
CYDY
CytoDyn
Last Price:
0.12
Seasonality Move:
24.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-10-09 | 10Q | CYDY/CytoDyn Quarterly |
| 2020-08-14 | 10K | CYDY/CytoDyn Annual |
| 2020-04-09 | 10Q | CYDY/CytoDyn Quarterly |
| 2020-01-09 | 10Q | CYDY/CytoDyn Quarterly |
| 2019-10-08 | 10Q | CYDY/CytoDyn Quarterly |
| 2019-08-14 | 10K | CYDY/CytoDyn Annual |
Receive CYDY News And Ratings
See the #1 stock for the next 7 days that we like better than CYDY
CYDY Financial Statistics
Sales & Book Value
| Annual Sales: | $266K |
|---|---|
| Cash Flow: | $5.44M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.07 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.01000 |
|---|---|
| Net Income (TTM): | $-19.04M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
CytoDyn Earnings Forecast
Key CytoDyn Financial Ratios
- The Selling, General & Administrative Expenses for CYDY have been equal to 16,655.26% of Gross Profit Margin.
- The Interest Expense is -11.51% of Operating Income.
- Per Share Earnings over the last 21 years have been positive in 10 years.
CytoDyn Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CYDY |
| Website: | cytodyn.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |